KR100734944B1 - 젖산칼슘 및 미강을 주재로 한 기능성 건강식품 조성물 - Google Patents
젖산칼슘 및 미강을 주재로 한 기능성 건강식품 조성물 Download PDFInfo
- Publication number
- KR100734944B1 KR100734944B1 KR1020070004165A KR20070004165A KR100734944B1 KR 100734944 B1 KR100734944 B1 KR 100734944B1 KR 1020070004165 A KR1020070004165 A KR 1020070004165A KR 20070004165 A KR20070004165 A KR 20070004165A KR 100734944 B1 KR100734944 B1 KR 100734944B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- food composition
- vitamin
- rice bran
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 title claims abstract description 11
- 235000011086 calcium lactate Nutrition 0.000 title claims abstract description 11
- 239000001527 calcium lactate Substances 0.000 title claims abstract description 11
- 229960002401 calcium lactate Drugs 0.000 title claims abstract description 11
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 10
- 235000009566 rice Nutrition 0.000 title claims abstract description 10
- 235000013402 health food Nutrition 0.000 title claims description 14
- 240000007594 Oryza sativa Species 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 claims abstract description 18
- 108090000790 Enzymes Proteins 0.000 claims abstract description 18
- 235000021329 brown rice Nutrition 0.000 claims abstract description 18
- 241000209094 Oryza Species 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 4
- 239000008187 granular material Substances 0.000 claims abstract description 4
- 239000003826 tablet Substances 0.000 claims abstract description 4
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 21
- 235000010755 mineral Nutrition 0.000 abstract description 21
- 239000011707 mineral Substances 0.000 abstract description 21
- 239000011575 calcium Substances 0.000 abstract description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 15
- 229960005069 calcium Drugs 0.000 abstract description 15
- 229910052791 calcium Inorganic materials 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 15
- 229940088594 vitamin Drugs 0.000 abstract description 12
- 229930003231 vitamin Natural products 0.000 abstract description 12
- 235000013343 vitamin Nutrition 0.000 abstract description 12
- 239000011782 vitamin Substances 0.000 abstract description 12
- 239000004470 DL Methionine Substances 0.000 abstract description 4
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract description 4
- 235000006109 methionine Nutrition 0.000 abstract description 4
- 229930182817 methionine Natural products 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 206010016256 fatigue Diseases 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 2
- 240000006439 Aspergillus oryzae Species 0.000 abstract 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 abstract 2
- 229930003779 Vitamin B12 Natural products 0.000 abstract 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 2
- 235000013376 functional food Nutrition 0.000 abstract 2
- 239000011715 vitamin B12 Substances 0.000 abstract 2
- 235000019163 vitamin B12 Nutrition 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 1
- 235000001465 calcium Nutrition 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 4
- 241000219061 Rheum Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940026510 theanine Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000017657 Menopausal disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Natural products N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 125000002235 cyanocobalamin group Chemical group 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000036562 nail growth Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
성분 | 현미 100g중의 함량 | |
단백질 | 7.4g | |
탄수화물 | 71.8g | |
식물섬유 | 3.4g | |
비타민 B1 | 0.54mg | |
비타민 B12 | 0.06mg | |
비타민 E | 1.6mg | |
나이아신 | 4.5mg | |
철 | 1.1mg | |
인 | 300mg | |
칼슘 | 10mg | |
나트륨 | 2mg | |
칼륨 | 250mg | |
휘친산 | 240mg |
Claims (3)
- 젖산칼슘 100중량부, DL-Methioine 1~10 중량부, 미강 0.1~5중량부, 현미효소 0.05~5중량부, 황국균 0.001~0.5중량부, 비타민 B12 0.001~0.5중량부를 함유함을 특징으로 하는 기능성 건강식품 조성물.
- 제1항에 있어서, DL-Methioine 5중량부, 미강 0.85중량부, 현미효소 0.1중량부, 황국균 0.005중량부, 비타민 B12 0.005중량부를 함유함을 특징으로 하는 기능성 건강식품 조성물.
- 제1항 또는 제2항에 있어서, 상기 조성물이 분말, 캡슐, 정제, 과립, 엑기스, 또는 음료의 제형인 것을 특징으로 하는 기능성 건강식품.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070004165A KR100734944B1 (ko) | 2007-01-15 | 2007-01-15 | 젖산칼슘 및 미강을 주재로 한 기능성 건강식품 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070004165A KR100734944B1 (ko) | 2007-01-15 | 2007-01-15 | 젖산칼슘 및 미강을 주재로 한 기능성 건강식품 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100734944B1 true KR100734944B1 (ko) | 2007-07-03 |
Family
ID=38503050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070004165A KR100734944B1 (ko) | 2007-01-15 | 2007-01-15 | 젖산칼슘 및 미강을 주재로 한 기능성 건강식품 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100734944B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100893661B1 (ko) | 2008-03-06 | 2009-04-17 | 최성훈 | 효소분해와 진공건조를 이용한 기능성 미강의 제조방법 |
CN106255420A (zh) * | 2014-03-28 | 2016-12-21 | 玛鲁哈日鲁株式会社 | 柑橘类果肉加工用组合物和使用其的果肉加工食品的制造方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020017197A (ko) | 2000-08-29 | 2002-03-07 | 최경호 | 효소 추출물을 이용한 기능성 식품 및 그 제조방법 |
KR20050053071A (ko) | 2003-12-02 | 2005-06-08 | 대한민국(강릉대학교총장) | 다시마 다당 및 올리고당 추출물을 함유하는 변비 개선 및예방용 기능성 식품 조성물 |
-
2007
- 2007-01-15 KR KR1020070004165A patent/KR100734944B1/ko active IP Right Review Request
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020017197A (ko) | 2000-08-29 | 2002-03-07 | 최경호 | 효소 추출물을 이용한 기능성 식품 및 그 제조방법 |
KR20050053071A (ko) | 2003-12-02 | 2005-06-08 | 대한민국(강릉대학교총장) | 다시마 다당 및 올리고당 추출물을 함유하는 변비 개선 및예방용 기능성 식품 조성물 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100893661B1 (ko) | 2008-03-06 | 2009-04-17 | 최성훈 | 효소분해와 진공건조를 이용한 기능성 미강의 제조방법 |
CN106255420A (zh) * | 2014-03-28 | 2016-12-21 | 玛鲁哈日鲁株式会社 | 柑橘类果肉加工用组合物和使用其的果肉加工食品的制造方法 |
CN106255420B (zh) * | 2014-03-28 | 2020-03-06 | 玛鲁哈日鲁株式会社 | 柑橘类果肉加工用组合物和使用其的果肉加工食品的制造方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108272073A (zh) | 一种减肥代餐粉及其制备方法 | |
CN104287049A (zh) | 一种体重管理的代餐蛋白质粉固体饮料 | |
JPH09191852A (ja) | 健康食品 | |
KR101539382B1 (ko) | 장 기능 개선 및 배변 촉진용 식품 조성물 | |
CN103976023A (zh) | 一种黄秋葵酸乳饮料及其制备方法 | |
WO2008014674A1 (fr) | Sel de potassium comestible nutritionnel et de soin ayant un large champ d'application | |
CN110771825A (zh) | 一种用于减脂、降血糖、降血压和降血脂的综合营养粉及其制备方法 | |
CN103371318B (zh) | 一种膳食营养补充食品 | |
CN105124347A (zh) | 一种辣木降血糖组合物及其制备方法 | |
KR101896024B1 (ko) | 가르시니아 캄보지아 추출물을 활용한 기능성 식품 조성물 및 이의 제조방법 | |
CN105707681A (zh) | 一种具有降血糖功能的超微黑木耳粉营养粥及其制备方法 | |
CN105341300A (zh) | 一种适宜儿童食用的保健糖果 | |
KR100734944B1 (ko) | 젖산칼슘 및 미강을 주재로 한 기능성 건강식품 조성물 | |
CN102018158A (zh) | 一种芦荟果酱 | |
CN103609748A (zh) | 一种降血糖孕妇奶粉及其制备方法 | |
CN103271353B (zh) | 一种护肝保健组合物及其制备方法 | |
KR20100037312A (ko) | 유산균을 이용한 분말형 건강보조식품의 제조방법 | |
CN101224005B (zh) | 一种具有全营养补充功效的营养片剂及其生产方法 | |
CN101129406A (zh) | 复方阿胶系列产品的配方和制造方法 | |
CN107455699A (zh) | 一种含木瓜的离子维c组合物及其制备方法 | |
CN103300424A (zh) | 一种螺旋藻糊及其制作方法 | |
JP2009034017A (ja) | ダイエット食品 | |
CN1631239B (zh) | 含有来源于米曲霉有机硒的酱油及其制备方法 | |
CN102599215A (zh) | 一种具有润肠通便功能的保健食品及其制备方法 | |
CN108850380A (zh) | 一种枸杞咖啡的配方及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20070115 |
|
PA0201 | Request for examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20070115 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
A302 | Request for accelerated examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20070515 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20070115 Patent event code: PA03021R01I Comment text: Patent Application |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20070531 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20070627 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20070627 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
J202 | Request for trial for correction [limitation] | ||
PJ0202 | Trial for correction |
Comment text: Request for Trial Patent event date: 20070830 Patent event code: PJ02022R01D Comment text: Registration of Establishment Patent event date: 20070627 Patent event code: PJ02021E01I Appeal kind category: Correction Decision date: 20071227 Request date: 20070830 Appeal identifier: 2007105000082 |
|
J301 | Trial decision |
Free format text: TRIAL DECISION FOR CORRECTION REQUESTED 20070830 Effective date: 20071227 |
|
PJ1301 | Trial decision |
Patent event code: PJ13011S03D Patent event date: 20071227 Comment text: Trial Decision on Correction (Patent, Utility Model) Appeal kind category: Correction Request date: 20070830 Decision date: 20071227 Appeal identifier: 2007105000082 |
|
PJ2001 | Appeal |
Patent event date: 20071227 Comment text: Trial Decision on Correction (Patent, Utility Model) Patent event code: PJ20011S03I Appeal kind category: Correction Decision date: 20090424 Appeal identifier: 2008205000996 Request date: 20080116 |
|
J302 | Written judgement (patent court) |
Free format text: JUDGMENT (PATENT COURT) FOR CORRECTION REQUESTED 20080116 Effective date: 20090424 |
|
PJ1302 | Judgment (patent court) |
Patent event date: 20090501 Comment text: Written Judgment (Patent Court) Patent event code: PJ13021S01D Request date: 20080116 Decision date: 20090424 Appeal identifier: 2008205000996 Appeal kind category: Correction |
|
PR1001 | Payment of annual fee |
Payment date: 20100610 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20110411 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20120406 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20130412 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20130412 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140605 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20140605 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150615 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20150615 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160617 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20160617 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180625 Year of fee payment: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20180625 Start annual number: 12 End annual number: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190626 Year of fee payment: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20190626 Start annual number: 13 End annual number: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20200629 Start annual number: 14 End annual number: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20210628 Start annual number: 15 End annual number: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20230627 Start annual number: 17 End annual number: 17 |
|
PR1001 | Payment of annual fee |
Payment date: 20240612 Start annual number: 18 End annual number: 18 |